MedPath

Subacromial Impingement Syndrome Approach Using High Intensity Laser Therapy

Not Applicable
Completed
Conditions
Subacromial Impingement
Interventions
Device: iLux Laser
Device: Sham ilux Laser
Registration Number
NCT02971215
Lead Sponsor
University of Castilla-La Mancha
Brief Summary

The purpose of this study is to assess the effectiveness of high intensity laser therapy in the treatment of subacromial impingement syndrome.

Detailed Description

Shoulder pain has a high prevalence in our society, several studies estimate an annual prevalence between 5% and 47%. It is one of the main causes of musculoskeletal pain, particularly in third place, after the low back pain and neck pain.

Symptoms of pathologies of subacromial space impingement syndrome, where, regardless of origin, pain is the number one symptom for the patient, which emanates functional impairment and the impact on quality of life. Because of the need to implement research to assess the effectiveness of high intensity laser therapy with new studies mayor methodological quality of obtaining conclusive results, and based on the scientific evidence supporting the low-power laser therapy as a useful tool in addressing the shoulder tendon pathology, we consider very interesting the realization of this research project.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Patients between 18 and 75 years old with diagnosis of subacromial impingement syndrome or any of the pathologies that compose it (tendinosis-tendinitis supraspinatus and rest of the rotator cuff, subacromial bursitis and tendinitis of the long head of the biceps).
  • Visual Analogue Scale (VAS) less than or equal to 7.
  • Forward flexion at least of 100º
Exclusion Criteria
  • Calcific tendinitis
  • Complete rupture of the rotator cuff.
  • Adhesive capsulitis.
  • Clinical history of pathologies that without affecting the shoulder joint refer to painful shoulder symptoms (cervical root involvement, cervical surgery, cervical osteoarthritis and neurological pathologies)
  • Fibromyalgia
  • Be receiving physiotherapeutic treatment or have received it previously for this pathology one month before the start of treatment.
  • Patients with alterations of thermal sensitivity.
  • Derived from the absolute and relative contraindications of Laser Therapy:
  • Photosensitive patients
  • Neoplastic processes
  • Hyperthyroidism
  • Pregnancy
  • Patients with a history of epileptic seizures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-intensity laser therapyiLux LaserHigh-intensity laser therapy application through iLux Laser device
Sham deviceSham ilux LaserSham high-intensity laser therapy application through sham iLux Laser device
Primary Outcome Measures
NameTimeMethod
Shoulder Pain and Disability Index (SPADI)three months after the end of the protocol treatment

SPADI test

Constant-Murley Scorethree months after the end of the protocol treatment

Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.

Quick-Dash Abbreviatedthree months after the end of the protocol treatment

Quick- Dash Abbreviated test

Secondary Outcome Measures
NameTimeMethod
Painful pressure threshold after first sessionFirst session - 15 minutes after laser or sham treatment.

The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton.

Painful pressure thresholdBaseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment

The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton.

VASBaseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment

Visual analogue scale

Trial Locations

Locations (1)

Hospital General Nuestra Señora del Prado

🇪🇸

Talavera de la Reina, Toledo, Spain

© Copyright 2025. All Rights Reserved by MedPath